Not applicableStudy completedNCT07465926
What this trial is testing
Early Add-On Combination of GLP-1 Receptor Agonist and SGLT2 Inhibitor in People With Cardiovascular-Kidney-Metabolic Stage 2-3
Who this might be right for
Cardiovascular-kidney-metabolic SyndromeCardiovascular Disease Risk FactorKidney Disease+2 more
Chung Shan Medical University 451,036